Lipoid pneumonia classification: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Lipoid pneumonia}} {{CMG}}; {{AE}} {{RG}} ==Overview== There is no established system for the classification of [disease name]. OR [Disease name] may be classif...")
 
 
(13 intermediate revisions by 4 users not shown)
Line 4: Line 4:
{{CMG}}; {{AE}} {{RG}}
{{CMG}}; {{AE}} {{RG}}
==Overview==
==Overview==
There is no established system for the classification of [disease name].


OR
[[Lipoid pneumonia]] may be classified according to source of the [[lipid]] exposure into 2 subtypes: [[Exogenous]], more common type reported, due to [[aspiration]] or [[inhalation]] of fatty [[substance]], and [[endogenous]], due to obstructive [[pneumonia]].
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==


There is no established system for the classification of [disease name].
* [[Lipoid pneumonia]] may be classified according to source of the [[lipid]] exposure into 2 subtypes:<ref name="pmid15443468">{{cite journal| author=BARON E| title=Lipoid pneumonia due to the use of mineral oil as a laxative. | journal=Va Med Mon (1918) | year= 1950 | volume= 77 | issue= 9 | pages= 448-50 | pmid=15443468 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15443468  }}</ref><ref name="GondouinManzoni1996">{{cite journal|last1=Gondouin|first1=A.|last2=Manzoni|first2=Ph.|last3=Ranfaing|first3=E.|last4=Brun|first4=J.|last5=Cadranel|first5=J.|last6=Sadoun|first6=D.|last7=Cordier|first7=J.F.|last8=Depierre|first8=A.|last9=Dalphin|first9=J.C.|title=Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France|journal=European Respiratory Journal|volume=9|issue=7|year=1996|pages=1463–1469|issn=00000000|doi=10.1183/09031936.96.09071463}}</ref>
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
*[Group1]
*[Group2]
*[Group3]
*[Group4]
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on:  
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
[Disease name] may be classified into several subtypes based on:
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
'''If the staging system involves specific and characteristic findings and features:'''
 
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR


The staging of [malignancy name] is based on the [staging system].


OR
{{Family tree/start}}
{{Family tree | | | | A01 | | | | |A01= '''[[Lipoid pneumonia]] classification'''}}
{{Family tree | | | | |!| | | | | | }}
{{Family tree | |,|-|-|^|-|-|-|.| | }}
{{Family tree | C01 | | | | C02 | |C01= '''Exogenus''':
More common type reported, due to [[aspiration]] or [[inhalation]] of [[Fatty-acid|fatty]] substance.| C02= '''Endogenus''':
Due to obstructive [[pneumonia]].}}
{{Family tree | | | | | | | |!| | | }}
{{Family tree | | | |,|-|-|-|+|-|-|.|}}
{{Family tree | | | D01||D02|| D03 |D01='''Type I'''
| D02='''Type II'''
| D03='''Type III''' }}
{{Family tree/end}}


There is no established system for the staging of [malignancy name].
*[[Endogenous]] [[pneumonia]] further divide into 3 subgroups:<ref name="TamuraHebisawa1998">{{cite journal|last1=Tamura|first1=A.|last2=Hebisawa|first2=A.|last3=Fukushima|first3=K.|last4=Yotsumoto|first4=H.|last5=Mori|first5=M.|title=Lipoid Pneumonia in Lung Cancer: Radiographic and Pathological Features|journal=Japanese Journal of Clinical Oncology|volume=28|issue=8|year=1998|pages=492–496|issn=0368-2811|doi=10.1093/jjco/28.8.492}}</ref>
** Type I: Localized to the [[lung]] [[parenchyma]] [[distal]] to an [[airway]] obstructed by a [[tumor]].
** Type II: Features of type I [[lipoid pneumonia]] and consecutively spreading to the adjacent segment whose airway is not affected.
** Type III: Features of type II [[lipoid pneumonia]] and spreading to isolated segments.<br /> <br />


==References==
==References==

Latest revision as of 23:41, 29 October 2019

Lipoid pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lipoid pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lipoid pneumonia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lipoid pneumonia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lipoid pneumonia classification

CDC on Lipoid pneumonia classification

Lipoid pneumonia classification in the news

Blogs on Lipoid pneumonia classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lipoid pneumonia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

Lipoid pneumonia may be classified according to source of the lipid exposure into 2 subtypes: Exogenous, more common type reported, due to aspiration or inhalation of fatty substance, and endogenous, due to obstructive pneumonia.

Classification


 
 
 
Lipoid pneumonia classification
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exogenus: More common type reported, due to aspiration or inhalation of fatty substance.
 
 
 
Endogenus: Due to obstructive pneumonia.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type IType IIType III

References

  1. BARON E (1950). "Lipoid pneumonia due to the use of mineral oil as a laxative". Va Med Mon (1918). 77 (9): 448–50. PMID 15443468.
  2. Gondouin, A.; Manzoni, Ph.; Ranfaing, E.; Brun, J.; Cadranel, J.; Sadoun, D.; Cordier, J.F.; Depierre, A.; Dalphin, J.C. (1996). "Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France". European Respiratory Journal. 9 (7): 1463–1469. doi:10.1183/09031936.96.09071463. ISSN 0000-0000.
  3. Tamura, A.; Hebisawa, A.; Fukushima, K.; Yotsumoto, H.; Mori, M. (1998). "Lipoid Pneumonia in Lung Cancer: Radiographic and Pathological Features". Japanese Journal of Clinical Oncology. 28 (8): 492–496. doi:10.1093/jjco/28.8.492. ISSN 0368-2811.

Template:WH Template:WS